• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年欧洲心脏健康调查。

European heart health survey 2019.

机构信息

Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen Nürnberg, Erlangen, Germany.

Institut Clínic Cardiovascular, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

出版信息

Clin Cardiol. 2020 Dec;43(12):1539-1546. doi: 10.1002/clc.23478. Epub 2020 Oct 28.

DOI:10.1002/clc.23478
PMID:33111998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7724240/
Abstract

BACKGROUND

Rising life expectancy in the western population is increasing the prevalence of heart valve diseases (HVD).

HYPOTHESIS

The level of awareness and initial screening for HVD should be sufficient. The potential impact of HVD on the daily activities of the elderly population in Europe might affect our society.

METHODS AND RESULTS

A survey was conducted, including a total of 12 832 people aged ≥ 60 years in 11 European countries. Of all the people surveyed, 5.6% could correctly describe aortic valve stenosis. Most participants (75.0%) claimed they regularly do activities like sports or social activities, 29.2% provide care for a family member, friend or acquaintance. The majority (69.2%) would be prevented from doing these activities by symptoms such as chest pain, fatigue or shortness of breath. Having chest pain (76.5%) and shortness of breath (57.8%) were reasons for most people to arrange an appointment with their GP, whereas only 26.2% would visit a GP for fatigue. 67.6% of respondents claimed to be checked with a stethoscope by their GP occasionally, never, or only when they ask. The preferred treatment option for HVD is a keyhole procedure (45.8%), whereas open heart surgery would only be preferred by 7.0%.

CONCLUSION

Knowledge about HVD is still low. Neither appointments with a GP driven by symptoms nor regular use of a stethoscope are a reliable guarantee for early diagnosis. With the over 60s in Europe playing an active role in social life, awareness campaigns and regular heart health checks may guarantee early diagnosis and treatment of HVD.

摘要

背景

西方人口预期寿命的上升导致心脏瓣膜疾病(HVD)的发病率不断上升。

假设

HVD 的知晓率和初步筛查应该足够。HVD 对欧洲老年人口日常活动的潜在影响可能会影响我们的社会。

方法和结果

在 11 个欧洲国家进行了一项调查,共纳入 12832 名年龄≥60 岁的人群。在所有接受调查的人群中,有 5.6%的人能够正确描述主动脉瓣狭窄。大多数参与者(75.0%)声称他们经常进行体育或社交活动等活动,29.2%的人照顾家庭成员、朋友或熟人。大多数人(69.2%)会因胸痛、疲劳或呼吸急促等症状而无法进行这些活动。胸痛(76.5%)和呼吸急促(57.8%)是大多数人预约全科医生的原因,而只有 26.2%的人会因疲劳而预约全科医生。67.6%的受访者声称他们的全科医生偶尔会用听诊器检查他们,也有从不检查或只有在他们要求时才检查的情况。HVD 的首选治疗方案是微创程序(45.8%),而开胸手术仅为 7.0%。

结论

人们对 HVD 的认识仍然很低。无论是由症状驱动的与全科医生的预约,还是定期使用听诊器,都不能可靠地保证早期诊断。由于欧洲 60 岁以上的人群在社会生活中发挥着积极的作用,因此开展宣传活动和定期进行心脏健康检查可能会保证 HVD 的早期诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/d9cd9da595fa/CLC-43-1539-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/4a4836633b79/CLC-43-1539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/12b64d591bd9/CLC-43-1539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/91b003f2d6df/CLC-43-1539-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/d9cd9da595fa/CLC-43-1539-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/4a4836633b79/CLC-43-1539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/12b64d591bd9/CLC-43-1539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/91b003f2d6df/CLC-43-1539-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/217d/7724240/d9cd9da595fa/CLC-43-1539-g004.jpg

相似文献

1
European heart health survey 2019.2019 年欧洲心脏健康调查。
Clin Cardiol. 2020 Dec;43(12):1539-1546. doi: 10.1002/clc.23478. Epub 2020 Oct 28.
2
Heart Valve Disease Awareness Survey 2017: what did we achieve since 2015?2017 年心脏瓣膜疾病认知调查:自 2015 年以来我们取得了哪些成就?
Clin Res Cardiol. 2019 Jan;108(1):61-67. doi: 10.1007/s00392-018-1312-5. Epub 2018 Jun 25.
3
Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over.主动脉瓣狭窄:人们了解多少?一项针对8800多名60岁及以上人群的心脏瓣膜疾病认知度调查。
EuroIntervention. 2016 Sep 18;12(7):883-9. doi: 10.4244/EIJY16M06_02.
4
Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.生物瓣外科主动脉瓣置换术后血流动力学瓣膜恶化的发生率、时间、相关性和结局。
Circulation. 2018 Sep 4;138(10):971-985. doi: 10.1161/CIRCULATIONAHA.118.035150.
5
[Heart valve disesases : How sufficient is the knowledge of the German population?].[心脏瓣膜疾病:德国民众的了解程度如何?]
Herz. 2019 Apr;44(2):161-169. doi: 10.1007/s00059-017-4632-8. Epub 2017 Oct 20.
6
Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.外科植入生物瓣主动脉瓣的血液动力学恶化。
J Am Coll Cardiol. 2018 Jul 17;72(3):241-251. doi: 10.1016/j.jacc.2018.04.064. Epub 2018 Jul 9.
7
Aortic valve stenosis awareness in Austria-results of a nationwide survey in 1001 subjects.奥地利主动脉瓣狭窄认知情况——一项针对1001名受试者的全国性调查结果
Wien Med Wochenschr. 2020 Apr;170(5-6):141-149. doi: 10.1007/s10354-019-00708-2. Epub 2019 Sep 20.
8
von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.血管性血友病因子与心脏瓣膜病的管理:美国心脏病学会评论专题之周。
J Am Coll Cardiol. 2019 Mar 12;73(9):1078-1088. doi: 10.1016/j.jacc.2018.12.045.
9
Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.心房颤动合并心脏瓣膜异常患者的卒中预防策略:对“瓣膜性”心房颤动的认知:欧洲心律协会调查结果
Europace. 2016 Oct;18(10):1593-1598. doi: 10.1093/europace/euw302.
10

引用本文的文献

1
Chest pain in a multi-ethnic population: A community-based study on sex differences in chest pain prevalence and care contacts.多民族人群中的胸痛:一项基于社区的胸痛患病率及就医接触性别差异研究
Int J Cardiol Cardiovasc Risk Prev. 2024 Dec 17;24:200361. doi: 10.1016/j.ijcrp.2024.200361. eCollection 2025 Mar.
2
Sex-related disparities in aortic stenosis from disease awareness to treatment: a state-of-the-art review.从疾病认知到治疗的主动脉瓣狭窄中的性别差异:最新综述
J Thorac Dis. 2024 Sep 30;16(9):6308-6319. doi: 10.21037/jtd-24-406. Epub 2024 Sep 21.
3
Creating a better journey of care for patients with heart valve disease.

本文引用的文献

1
Lower mortality in an all-comers aortic stenosis population treated with TAVI in comparison to SAVR.经 TAVI 治疗的所有主动脉瓣狭窄患者的死亡率低于 SAVR。
Clin Res Cardiol. 2020 May;109(5):611-615. doi: 10.1007/s00392-019-01548-1. Epub 2019 Oct 1.
2
Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.经导管主动脉瓣植入术与保守治疗用于真实临床实践中的重度主动脉瓣狭窄。
PLoS One. 2019 Sep 26;14(9):e0222979. doi: 10.1371/journal.pone.0222979. eCollection 2019.
3
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
为心脏瓣膜病患者打造更优质的护理之旅。
Eur Heart J Open. 2021 Nov 9;1(3):oeab034. doi: 10.1093/ehjopen/oeab034. eCollection 2021 Nov.
经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
4
Heart Valve Disease Awareness Survey 2017: what did we achieve since 2015?2017 年心脏瓣膜疾病认知调查:自 2015 年以来我们取得了哪些成就?
Clin Res Cardiol. 2019 Jan;108(1):61-67. doi: 10.1007/s00392-018-1312-5. Epub 2018 Jun 25.
5
Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure.经皮植入后 5 年以上自膨式经导管心脏瓣膜的长期耐久性和血液动力学性能:应用结构性退化和瓣膜失效的标准化定义进行的前瞻性观察研究。
EuroIntervention. 2018 Jul 20;14(4):e390-e396. doi: 10.4244/EIJ-D-18-00041.
6
Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.采用新的欧洲共识定义评估经导管主动脉生物瓣球囊扩张瓣的结构性瓣膜衰败。
EuroIntervention. 2018 Jun 8;14(3):e264-e271. doi: 10.4244/EIJ-D-18-00015.
7
Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices.五年后展望:第一代器械行经导管主动脉瓣置换术治疗高危且不可手术患者的长期结局。
EuroIntervention. 2018 May 20;14(1):41-49. doi: 10.4244/EIJ-D-17-00603.
8
Outcome after transvascular transcatheter aortic valve implantation in 2016.2016 年经血管经导管主动脉瓣植入术后的结果。
Eur Heart J. 2018 Feb 21;39(8):667-675. doi: 10.1093/eurheartj/ehx688.
9
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
10
Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study.经导管二尖瓣修复系统 PASCAL 在重度二尖瓣反流患者中的同情使用:多中心、前瞻性、观察性、首例人体研究。
Lancet. 2017 Aug 19;390(10096):773-780. doi: 10.1016/S0140-6736(17)31600-8.